Komori
Share Issuance and Disposal4563AnGes,Inc.Pharmaceuticals

Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Adjustment Provisions

No Series 46 stock acquisition rights with an exercise price adjustment clause were exercised in June 2026, and the number of shares delivered was 0. The number of unexercised rights at month-end was 837,171, unchanged from the end of the previous month.

Worth reading
45Recurring
Scored from 2 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
0
Shares
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Stock Acquisition Rights with Exercise Price Adjustment Clauses

発行済株式総数

0.00% (exercise ratio for the month)

The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.

Terms of the stock acquisition rights
Exercise price
¥40.0–¥44.1 (exercise prices on the respective exercise dates in June 2026). For details of the adjustment clause, see the materials released on 7 November 2025.
Number of Stock Acquisition Rights
Exercise ratio relative to the total number issued: 0.00%; 837,171 as of the end of the month preceding the reporting month; 837,171 as of the end of the reporting month
Procedures under the Corporate Code of Conduct
Describes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the rules of the Japan Securities Dealers Association
Most recent equity financing
Issued on 25 November 2025; Series 46 stock acquisition rights with an exercise price adjustment clause; amount: not disclosed
Details of issuance or disposal
ItemDetails
Type of issuance or disposalStock Acquisition Rights with Exercise Price Adjustment Clauses
Dilution Rate0.00% (exercise ratio for the month)
Total number of issued shares398,834,550 shares (as of the end of the month preceding the reporting month) → Not disclosed
Exercise price¥40.0–¥44.1 (exercise prices on the respective exercise dates in June 2026). For details of the adjustment clause, see the materials released on 7 November 2025.
Number of Stock Acquisition RightsExercise ratio relative to the total number issued: 0.00%; 837,171 as of the end of the month preceding the reporting month; 837,171 as of the end of the reporting month
Procedures under the Corporate Code of ConductDescribes compliance with exercise restrictions under Article 434 of the Tokyo Stock Exchange Securities Listing Regulations and the rules of the Japan Securities Dealers Association
Most recent equity financingIssued on 25 November 2025; Series 46 stock acquisition rights with an exercise price adjustment clause; amount: not disclosed
Items this document does not state (21)
Number of shares to be issued or disposed ofIssue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allotteeIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company reported its monthly exercise status; no reason was given for the lack of exercise.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Monthly Exercise Status of Stock Acquisition Rights with Exercise Price Adjustment Provisions | AnGes,Inc. (4563) timely disclosure | Komori